Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP

BACKGROUND: The ever-present threat of infectious disease, e.g. influenza pandemics, and the increasing need for new and effective treatments in immunotherapy are the driving forces that motivate research into new and innovative vaccine platforms. Ideally, such platforms should trigger an efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Babin, Cindy, Majeau, Nathalie, Leclerc, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621093/
https://www.ncbi.nlm.nih.gov/pubmed/23556511
http://dx.doi.org/10.1186/1477-3155-11-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621093/
https://www.ncbi.nlm.nih.gov/pubmed/23556511
http://dx.doi.org/10.1186/1477-3155-11-10

Ejemplares similares